Biosimilars for the Treatment of Psoriasis A Systematic Review of Clinical Trials and Observational Studies
JAMA Dermatology, 2023.
Duc Binh Phan; Sarah Elyoussfi; Michael Stevenson; Mark Lunt; Richard B. Warren; Zenas Z. N. Yiu
Read publication: JAMA Dermatology
Related
Uptake of tumour necrosis factor - alpha inhibitor biosimilars for psoriasis: A drug utilisation stu...
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Sec...
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the Br...
0 Comments